82 related articles for article (PubMed ID: 17848952)
1. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
[TBL] [Abstract][Full Text] [Related]
2. Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.
Chen T; Wei W; Zhang J; Yu J; Xu S; Wu D; Li X; Chen J
J Neurosurg; 2023 Dec; 139(6):1705-1714. PubMed ID: 37347656
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor signaling in acute myeloid leukemia.
Kampen KR; Ter Elst A; de Bont ES
Cell Mol Life Sci; 2013 Apr; 70(8):1307-17. PubMed ID: 22833169
[TBL] [Abstract][Full Text] [Related]
4. Chemerin affects the expression of angiogenesis-related factors in the porcine endometrium during early pregnancy and the oestrous cycle: an
Kiezun M; Dobrzyn K; Kiezun J; Kaminski T; Smolinska N
Reprod Fertil Dev; 2023 Nov; 35(16):692-707. PubMed ID: 37955271
[TBL] [Abstract][Full Text] [Related]
5. The possible dual role of Ang-2 in the prognosis of pancreatic cancer.
Roos-Mattila M; Kaprio T; Mustonen H; Hagström J; Saharinen P; Haglund C; Seppänen H
Sci Rep; 2023 Oct; 13(1):18725. PubMed ID: 37907568
[TBL] [Abstract][Full Text] [Related]
6. Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis.
Roesler J; Spitzer D; Jia X; Aasen SN; Sommer K; Roller B; Olshausen N; Hebach NR; Albinger N; Ullrich E; Zhu L; Wang F; Macas J; Forster MT; Steinbach JP; Sevenich L; Devraj K; Thorsen F; Karreman MA; Plate KH; Reiss Y; Harter PN
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38831719
[TBL] [Abstract][Full Text] [Related]
7. Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.
Kiani-Zadeh M; Rezvany MR; Namjoo S; Barati M; Mohammadi MH; Ghasemi B; Tabatabaei T; Ghavamzadeh A; Zaker F; Teimoori-Toolabi L
Mol Biol Rep; 2022 Aug; 49(8):7849-7862. PubMed ID: 35733068
[TBL] [Abstract][Full Text] [Related]
8. Investigating the expression pattern of the angiopoietin-Tie system in ALL and its correlation with baseline characteristics.
Khosravi SZ; Ramshe SM; Farsani MA; Solali S; Moonesi M; Hagh MF
Blood Res; 2021 Jun; 56(2):79-85. PubMed ID: 34031276
[TBL] [Abstract][Full Text] [Related]
9. Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells.
Shi H; Li XY; Chen Y; Zhang X; Wu Y; Wang ZX; Chen PH; Dai HQ; Feng J; Chatterjee S; Li ZJ; Huang XW; Wei HQ; Wang J; Lu GD; Zhou J
Front Pharmacol; 2020; 11():534171. PubMed ID: 33362534
[TBL] [Abstract][Full Text] [Related]
10. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow Blood Vessels: Normal and Neoplastic Niche.
Shahrabi S; Rezaeeyan H; Ahmadzadeh A; Shahjahani M; Saki N
Oncol Rev; 2016 Oct; 10(2):306. PubMed ID: 27994770
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy analysis of CAG priming regimen combined with talidomide, interferon and interleukin 2 as the induction therapy for relapsed refractory acute myeloid leukemia].
Zu Y; Zhang Y; Zhou J; Zhao H; Gui R; Li Z; Li M; Wei X; Song Y
Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):334-6. PubMed ID: 27093999
[No Abstract] [Full Text] [Related]
13. Serum Angiopoietin Levels are Different in Acute and Chronic Myeloid Neoplasms: Angiopoietins do not only Regulate Tumor Angiogenesis.
Atesoglu EB; Tarkun P; Mehtap O; Demirsoy ET; Atalay F; Maden M; Celebi K; Hacihanefioglu A
Indian J Hematol Blood Transfus; 2016 Jun; 32(2):162-7. PubMed ID: 27065577
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide Effect on Vascular Endothelial Factor and Matrix Metalloproteinases in Leukemic Cell Lines In vitro.
Hajighasemi F; Gheini MH
Iran J Cancer Prev; 2015 May; 8(3):e2327. PubMed ID: 26413247
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell derived angiocrine support of acute myeloid leukemia targeted by receptor tyrosine kinase inhibition.
Drusbosky L; Gars E; Trujillo A; McGee C; Meacham A; Wise E; Scott EW; Cogle CR
Leuk Res; 2015 Sep; 39(9):984-9. PubMed ID: 26189107
[TBL] [Abstract][Full Text] [Related]
16. Does Chemotherapy Change Expression of VEGF A&C and MVD in Acute Myeloid Leukemia?
Sanaat Z; Khalili R; Almasi S; Aliparasti MR; Tavangar SM; Movasaghpoor A; Kazemi F; Davani A
Int J Hematol Oncol Stem Cell Res; 2014 Jul; 8(3):24-9. PubMed ID: 25642305
[TBL] [Abstract][Full Text] [Related]
17. Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation.
Bruserud Ø; Reikvam H; Fredly H; Skavland J; Hagen KM; van Hoang TT; Brenner AK; Kadi A; Astori A; Gjertsen BT; Pendino F
Oncotarget; 2015 Feb; 6(5):2794-811. PubMed ID: 25605239
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression of VEGF-A and VEGF-C in Peripheral Blood Mononuclear Cells of Iranian Patients with Acute Myeloid Leukemia.
Aliparasti MR; Almasi S; Sanaat Z; Movasaghpoor A; Khalili-Dizaji R; Sadeghi-Bazargani H
Turk J Haematol; 2013 Jun; 30(2):137-43. PubMed ID: 24385776
[TBL] [Abstract][Full Text] [Related]
19. Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling.
Weidenaar AC; ter Elst A; Kampen KR; Meeuwsen-de Boer TG; de Jonge HJ; Scherpen FJ; den Dunnen WF; Kamps WA; de Bont ES
Br J Cancer; 2011 Dec; 105(12):1856-63. PubMed ID: 22045186
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.
Penack O; Henke E; Suh D; King CG; Smith OM; Na IK; Holland AM; Ghosh A; Lu SX; Jenq RR; Liu C; Murphy GF; Lu TT; May C; Scheinberg DA; Gao DC; Mittal V; Heller G; Benezra R; van den Brink MR
J Natl Cancer Inst; 2010 Jun; 102(12):894-908. PubMed ID: 20463307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
